Thioridazine protects against disturbed flow-induced atherosclerosis by inhibiting RhoA/YAP-mediated endothelial inflammation
Minchun Jiang, Hanyi Ding, Yühong Huang, Chak Kwong Cheng, Chi Wai Lau, Yin Xia, Xiaoqiang Yao, Li Wang, Yü Huang
Topics & Concepts
ThioridazineRHOAEndothelial dysfunctionPharmacologyInflammationIn vivoMedicineSignal transductionBiologyImmunologyCell biologyInternal medicineBiotechnologyChlorpromazineHippo pathway signaling and YAP/TAZ